Nano-scale particles have attracted research attention due to their differences in properties such as penetration, circulation, and toxicity compared to bulk materials. This thesis mainly focused on using 20 nm iron oxide nanoparticles as siRNA delivery carriers under the alternating magnetic field and the development of a method to amplify the secretion of 150 nm exosomes from the cells, which could potentially use as a biological drug carrier. Chapter 2 discusses a magnetically driven nanoparticle therapeutic agent delivery system, which efficiently modified the gene expression post-transcriptionally. In this work, we examined whether the caged-shaped 20nm iron oxide nanoparticles (IO-nanocages) can escape from the endosomes when an alter...
A major challenge of cancer treatment is successful discrimination of cancer cells from healthy cell...
The aim of this project was to develop a platform technology for the delivery of Magnetic Nanopartic...
Even though the administration of chemotherapeutic agents such as erlotinib is clinically establishe...
Thesis (Ph.D.)--University of Washington, 2015-12Gene therapy shows promise for individualized cance...
Gene delivery technologies to introduce foreign genes into highly differentiated mammalian cells hav...
The safe, targeted and effective delivery of gene therapeutics remains a significant barrier to thei...
The rising demand for complex biological therapies (i.e., personalized medicine) has created an urge...
The safe, targeted and effective delivery of gene therapeutics remains a significant barrier to thei...
Recent breakthroughs in employing magnetic iron oxide nanoparticles (IONPs) to improve gene transmis...
Using magnetic nanoparticles to absorb alternating magnetic field energy as a method of generating ...
In this review, we discuss the recent advances in and problems with the use of magnetically-guided a...
Magnetically applied forces present the ability to manipulate paramagnetic nanoparticles for a wide ...
With the advent of powerful gene editing tools such as CRISPR/Cas9, advances in gene therapy have ga...
Superparamagnetic iron oxide nanoparticles provide a platform to deliver therapeutic agents to any d...
WOS: 000431499100008PubMed: 29082480Magnetosomes are specialized organelles arranged in intracellula...
A major challenge of cancer treatment is successful discrimination of cancer cells from healthy cell...
The aim of this project was to develop a platform technology for the delivery of Magnetic Nanopartic...
Even though the administration of chemotherapeutic agents such as erlotinib is clinically establishe...
Thesis (Ph.D.)--University of Washington, 2015-12Gene therapy shows promise for individualized cance...
Gene delivery technologies to introduce foreign genes into highly differentiated mammalian cells hav...
The safe, targeted and effective delivery of gene therapeutics remains a significant barrier to thei...
The rising demand for complex biological therapies (i.e., personalized medicine) has created an urge...
The safe, targeted and effective delivery of gene therapeutics remains a significant barrier to thei...
Recent breakthroughs in employing magnetic iron oxide nanoparticles (IONPs) to improve gene transmis...
Using magnetic nanoparticles to absorb alternating magnetic field energy as a method of generating ...
In this review, we discuss the recent advances in and problems with the use of magnetically-guided a...
Magnetically applied forces present the ability to manipulate paramagnetic nanoparticles for a wide ...
With the advent of powerful gene editing tools such as CRISPR/Cas9, advances in gene therapy have ga...
Superparamagnetic iron oxide nanoparticles provide a platform to deliver therapeutic agents to any d...
WOS: 000431499100008PubMed: 29082480Magnetosomes are specialized organelles arranged in intracellula...
A major challenge of cancer treatment is successful discrimination of cancer cells from healthy cell...
The aim of this project was to develop a platform technology for the delivery of Magnetic Nanopartic...
Even though the administration of chemotherapeutic agents such as erlotinib is clinically establishe...